Breaking News

Molecular Profiles Joins Formulation Development Consortium

Aims to expedite the development of pediatric formulations

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Molecular Profiles has joined a UK consortium, led by Astra Zeneca, focused on improving the pathway for developing pediatric formulations. The consortium recently received a grant from the UK’s Technology Strategy Board, to help fund a £1 million project aimed at accelerating pediatric formulation development through design and predictive science.   The consortium is comprised of pharmaceutical analytical development specialist Molecular Profiles, along with Pfizer, Bristol-Myers Squibb, GlaxoS...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters